Recent Acquisitions Lantheus Holdings, Inc has recently acquired Meilleur Technologies, enhancing its capabilities in Alzheimer's disease diagnostics. This acquisition could open up new sales opportunities in the neurology and radiopharmaceutical sectors.
Key Personnel Additions The appointment of Julie Eastland to Lantheus' Board of Directors and Jamie Spaeth as Chief People Officer demonstrates the company's focus on strengthening leadership. Leveraging connections and expertise of these new hires could help in expanding sales networks and strategies.
Strategic Investment Hillsdale Investment Management Inc.'s significant investment in Lantheus Holdings indicates confidence in the company's future prospects. This vote of confidence can be leveraged by the sales team to approach new investors and clients with increased credibility and financial backing.
Advanced Technology Stack Lantheus utilizes a robust tech stack including Azure Monitor, AutoCad, and Informatica, showcasing a commitment to innovation and efficiency. This technological advantage can be highlighted to potential clients to demonstrate the company's readiness for cutting-edge solutions and partnerships.
Scientific Expertise Boost The recent addition of Jeffrey S. Humphrey as Chief Scientific Officer further bolsters Lantheus' scientific capabilities. Leveraging Dr. Humphrey's expertise in the medical field could help position the company as a trusted partner for research institutions and healthcare providers, potentially leading to increased sales in the medical imaging and therapeutics segments.
92K
$1B
1.5K$100M$1B
57K$1B
3.4K$1B
2.5K$100M$1BLantheus uses 8 technology products and services including Azure Monitor, AutoCad, SurveyMonkey, and more. Explore Lantheus's tech stack below.
| Lantheus Email Formats | Percentage |
| First.Last@lantheus.com | 92% |
| First.L@lantheus.com | 5% |
| LastF@lantheus.com | 2% |
| Last.First@lantheus.com | 1% |
Pharmaceutical ManufacturingMassachusetts, United States1001-5000 Employees
About us With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden.
Company Overview
Media & News
Funding & FinancialsLantheus's revenue is in the range of $100M$1B
Funding & FinancialsLantheus's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com